Company: NIVFW
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001213900-25-079717
Chunk: 152

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-22
Form: DRS
Chunk 152
---
 the washing, the
sample is stained with a special fluorescent material that attaches to the DNA contained in the sperm. The stained sperm cells are analyzed
one by one by a flow cytometer, in which cells pass through a laser to make the stain attach to the DNA fluoresce. The sperm containing
the X chromosome (which have more DNA and therefore more stain) will shine brighter than the sperm containing the Y chromosome. The
flow cytometer uses a special software to identify X and Y chromosome sperm based on their fluorescence signature. The sperm
carrying the chromosome that will produce the desired gender are separated from the rest of the sample -resulting in an enriched sperm
sample ready for use.

NewGenIvf held an exclusive
license granted by a division of GIVF, MicroSort International, to use the MicroSort technology in Thailand and Cambodia. MicroSort’s
licenses for NewGenIvf’s operation in Thailand and Cambodia were each provided under a lease and service agreement. In April 2019,
First Fertility PGS entered into a Lease and Services Agreement with MicroSort International to use MicroSort equipment in Thailand and
in March 2019, Phnom Penh Center entered into a Lease and Services Agreement with MicroSort International to use MicroSort equipment in
Cambodia (together, the “Lease and Services Agreements”). Pursuant to the Lease and Services Agreements, First Fertility PGS
and Phnom Penh Center each had the exclusive right to utilize the MicroSort equipment and to market and sell MicroSort sperm sorting services
in Thailand and Cambodia, respectively. MicroSort International was responsible for the maintenance of MicroSort equipment and technical
and engineering support. The term of each Lease and Service Agreements was initially from 2019 to 2024, which shall be automatically renewed
for one year unless a written notice of at least 180 days prior to the intended termination date is provided. The consideration under
each of the Lease and Services Agreements was US$9,000 per month after six months.

<div align='center'>84</div>

On February 28, 2025, NewGenIvf
completed its acquisition of the MicroSort technology from Genetics & IVF Institute, Inc. (“GIVF”). Pursuant to a Purchase
Agreement dated January 21, 2025 between NewGenIvf and GIVF (“Purchase Agreement”), NewGenIvf purchased all of the Assets
(as defined in the Purchase Agreement) and IP Licenses